Early research (Phase 1)WithdrawnNCT02914327What this trial is testingSafety and Activity of SNX-5422 Plus Ibrutinib in CLLWho this might be right forCancer Esanex Inc.
Testing effectiveness (Phase 2)Study completedNCT01930162What this trial is testingSafety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood TransplantWho this might be right forSingle Umbilical Cord Blood TransplantationNon-myeloablative ConditioningAcute Lymphocytic Leukemia+4 more Novartis Pharmaceuticals 9
Early research (Phase 1)Study completedNCT01650727What this trial is testingDinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974)Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Merck Sharp & Dohme LLC 5
Early research (Phase 1)Study completedNCT00005580What this trial is testingBryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Virginia Commonwealth University 54
Testing effectiveness (Phase 2)Study completedNCT00438880What this trial is testingAgatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin LymphomaWho this might be right forAdult Non-Hodgkin LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone Lymphoma+9 more Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT00096096What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00514696What this trial is testingStudy of the Safety of GCS-100 in Subjects With Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia La Jolla Pharmaceutical Company 12
Testing effectiveness (Phase 2)Study completedNCT00489203What this trial is testingBeclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forHematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more Fred Hutchinson Cancer Center 140
Early research (Phase 1)Ended earlyNCT02336048What this trial is testingA Study Evaluating the Safety of Tocilizumab in Addition to Standard of Care Premedication Given Before Obinutuzumab + Chlorambucil in Participants With Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL) and ComorbiditiesWho this might be right forB-Cell Chronic Lymphocytic Leukemia Hoffmann-La Roche 38
Testing effectiveness (Phase 2)WithdrawnNCT02677948What this trial is testingMulticenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Who this might be right forChronic Lymphocytic LeukemiaLymphoma, Small Lymphocytic University of Michigan Rogel Cancer Center
Not applicableUnknownNCT05360758What this trial is testingIbrutinib Adapted to Response in Patients With CLLWho this might be right forChronic Lymphocytic Leukemia Grupo Argentino de Tratamiento de la Leucemia Aguda 80
Testing effectiveness (Phase 2)WithdrawnNCT01670084What this trial is testingNilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous LeukemiaWho this might be right forB-cell Adult Acute Lymphoblastic LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+2 more Mayo Clinic
Early research (Phase 1)Study completedNCT00019838What this trial is testingUCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or LeukemiaWho this might be right forLeukemiaLymphoma National Cancer Institute (NCI)
Not applicableNot Yet RecruitingNCT07476378What this trial is testingEvaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell MalignanciesWho this might be right forLymphoma, Large B-Cell, Diffuse (DLBCL)Lymphoma, FollicularLymphoma, Mantle-Cell+3 more Cancer Institute and Hospital, Chinese Academy of Medical Sciences 69
Not applicableLooking for participantsNCT07288515What this trial is testingObserv Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in BelarusWho this might be right forChronic Lymphocytic Leukemia AstraZeneca 50
Early research (Phase 1)Looking for participantsNCT03595917What this trial is testingABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CMLWho this might be right forB-cell Acute Lymphoblastic LeukemiaChronic Myeloid Leukemia (CML) in Lymphoid Blast CrisisPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL Marlise Luskin, MD 40
Not applicableStudy completedNCT00890435What this trial is testingDecision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialWho this might be right forBrain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more Children's Oncology Group 53
Testing effectiveness (Phase 2)Study completedNCT03685708What this trial is testingHEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)Who this might be right forHepatitisSafety and Tolerability National Heart, Lung, and Blood Institute (NHLBI) 78
Testing effectiveness (Phase 2)Study completedNCT00724984What this trial is testingStudy of the Safety and Tolerability of PCI-24781 in Patients With LymphomaWho this might be right forLymphomaHodgkin DiseaseLymphoma, Non-Hodgkin Pharmacyclics LLC. 55
Not applicableStudy completedNCT00481858What this trial is testingKinetic Biomarker for Chronic Lymphocytic Leukemia PrognosisWho this might be right forChronic Lymphocytic Leukemia KineMed 150